A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma

We previously used a pulse-based in vitro assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et al., 2020). Here, we advanced this model system and identified a non-genetic mechanism of resistance that drives recovery and regro...

Full description

Saved in:
Bibliographic Details
Published in:eLife Vol. 10
Main Authors: Gonzalez Rajal, Alvaro, Marzec, Kamila A, McCloy, Rachael A, Nobis, Max, Chin, Venessa, Hastings, Jordan F, Lai, Kaitao, Kennerson, Marina, Hughes, William E, Vaghjiani, Vijesh, Timpson, Paul, Cain, Jason E, Watkins, D Neil, Croucher, David R, Burgess, Andrew
Format: Journal Article
Language:English
Published: England eLife Science Publications, Ltd 13.05.2021
eLife Sciences Publications Ltd
eLife Sciences Publications, Ltd
Subjects:
53BP1
Adenocarcinoma
Biosensors
BRCA1
Cancer Biology
Cancer therapies
Carboplatin
Cell Biology
Cell cycle
Cisplatin
Cyclin-dependent kinases
Deoxyribonucleic acid
DNA
DNA damage
DNA repair
Flow cytometry
G2 phase
Kinases
Lung cancer
mitosis
Ovaries
PARP1
Poly(ADP-ribose) polymerase
Research Advance
S phase
Senescence
Signal transduction
Testicular cancer
Fiji
human
cancer biology
cell biology
ISSN:2050-084X, 2050-084X
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract We previously used a pulse-based in vitro assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et al., 2020). Here, we advanced this model system and identified a non-genetic mechanism of resistance that drives recovery and regrowth in a subset of cells. Using RNAseq and a suite of biosensors to track single-cell fates both in vitro and in vivo, we identified that early S phase cells have a greater ability to maintain proliferative capacity, which correlated with reduced DNA damage over multiple generations. In contrast, cells in G1, late S or those treated with PARP/RAD51 inhibitors, maintained higher levels of DNA damage and underwent prolonged S/G2 phase arrest and senescence. Combined with our previous work, these data indicate that there is a non-genetic mechanism of resistance in human lung adenocarcinoma that is dependent on the cell cycle stage at the time of cisplatin exposure.
AbstractList We previously used a pulse-based assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et al., 2020). Here we advanced this model system and identified a non-genetic mechanism of resistance that drives recovery and regrowth in a subset of cells. Using RNAseq and a suite of biosensors to track single cell fates both and we identified that early S phase cells have a greater ability to maintain proliferative capacity, which correlated with reduced DNA damage over multiple generations. In contrast, cells in G1, late S or those treated with PARP/RAD51 inhibitors, maintained higher levels of DNA damage and underwent prolonged S/G2 phase arrest and senescence. Combined with our previous work, these data indicate that there is a non-genetic mechanism of resistance in human lung adenocarcinoma that is dependent on the cell cycle stage at the time of cisplatin exposure.
We previously used a pulse-based in vitro assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et al., 2020). Here, we advanced this model system and identified a non-genetic mechanism of resistance that drives recovery and regrowth in a subset of cells. Using RNAseq and a suite of biosensors to track single-cell fates both in vitro and in vivo, we identified that early S phase cells have a greater ability to maintain proliferative capacity, which correlated with reduced DNA damage over multiple generations. In contrast, cells in G1, late S or those treated with PARP/RAD51 inhibitors, maintained higher levels of DNA damage and underwent prolonged S/G2 phase arrest and senescence. Combined with our previous work, these data indicate that there is a non-genetic mechanism of resistance in human lung adenocarcinoma that is dependent on the cell cycle stage at the time of cisplatin exposure.
We previously used a pulse-based in vitro assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et al., 2020). Here, we advanced this model system and identified a non-genetic mechanism of resistance that drives recovery and regrowth in a subset of cells. Using RNAseq and a suite of biosensors to track single-cell fates both in vitro and in vivo, we identified that early S phase cells have a greater ability to maintain proliferative capacity, which correlated with reduced DNA damage over multiple generations. In contrast, cells in G1, late S or those treated with PARP/RAD51 inhibitors, maintained higher levels of DNA damage and underwent prolonged S/G2 phase arrest and senescence. Combined with our previous work, these data indicate that there is a non-genetic mechanism of resistance in human lung adenocarcinoma that is dependent on the cell cycle stage at the time of cisplatin exposure.We previously used a pulse-based in vitro assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et al., 2020). Here, we advanced this model system and identified a non-genetic mechanism of resistance that drives recovery and regrowth in a subset of cells. Using RNAseq and a suite of biosensors to track single-cell fates both in vitro and in vivo, we identified that early S phase cells have a greater ability to maintain proliferative capacity, which correlated with reduced DNA damage over multiple generations. In contrast, cells in G1, late S or those treated with PARP/RAD51 inhibitors, maintained higher levels of DNA damage and underwent prolonged S/G2 phase arrest and senescence. Combined with our previous work, these data indicate that there is a non-genetic mechanism of resistance in human lung adenocarcinoma that is dependent on the cell cycle stage at the time of cisplatin exposure.
Audience Academic
Author Nobis, Max
Burgess, Andrew
Kennerson, Marina
Hastings, Jordan F
Watkins, D Neil
Gonzalez Rajal, Alvaro
Marzec, Kamila A
Cain, Jason E
Chin, Venessa
Hughes, William E
Vaghjiani, Vijesh
Croucher, David R
Lai, Kaitao
Timpson, Paul
McCloy, Rachael A
Author_xml – sequence: 1
  givenname: Alvaro
  orcidid: 0000-0002-9230-0339
  surname: Gonzalez Rajal
  fullname: Gonzalez Rajal, Alvaro
  organization: ANZAC Research Institute, Concord Hospital, Concord, Australia, Garvan Institute of Medical Research, Sydney, Australia, St Vincent's Hospital Clinical School, University of New South Wales, Sydney, Australia
– sequence: 2
  givenname: Kamila A
  orcidid: 0000-0002-3051-2205
  surname: Marzec
  fullname: Marzec, Kamila A
  organization: ANZAC Research Institute, Concord Hospital, Concord, Australia
– sequence: 3
  givenname: Rachael A
  surname: McCloy
  fullname: McCloy, Rachael A
  organization: The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia
– sequence: 4
  givenname: Max
  orcidid: 0000-0002-1861-1390
  surname: Nobis
  fullname: Nobis, Max
  organization: St Vincent's Hospital Clinical School, University of New South Wales, Sydney, Australia, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia
– sequence: 5
  givenname: Venessa
  surname: Chin
  fullname: Chin, Venessa
  organization: St Vincent's Hospital Clinical School, University of New South Wales, Sydney, Australia, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia, St Vincent’s Hospital Sydney, Darlinghurst, Australia
– sequence: 6
  givenname: Jordan F
  orcidid: 0000-0003-2839-4358
  surname: Hastings
  fullname: Hastings, Jordan F
  organization: The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia
– sequence: 7
  givenname: Kaitao
  orcidid: 0000-0002-9420-9352
  surname: Lai
  fullname: Lai, Kaitao
  organization: ANZAC Research Institute, Concord Hospital, Concord, Australia, The University of Sydney Concord Clinical School, Faculty of Medicine and Health, Sydney, Australia
– sequence: 8
  givenname: Marina
  orcidid: 0000-0003-3332-5074
  surname: Kennerson
  fullname: Kennerson, Marina
  organization: ANZAC Research Institute, Concord Hospital, Concord, Australia, The University of Sydney Concord Clinical School, Faculty of Medicine and Health, Sydney, Australia
– sequence: 9
  givenname: William E
  surname: Hughes
  fullname: Hughes, William E
  organization: Garvan Institute of Medical Research, Sydney, Australia, St Vincent's Hospital Clinical School, University of New South Wales, Sydney, Australia, Children’s Medical Research Institute, The University of Sydney, Westmead, Australia
– sequence: 10
  givenname: Vijesh
  surname: Vaghjiani
  fullname: Vaghjiani, Vijesh
  organization: Hudson Institute of Medical Research, Clayton, Australia
– sequence: 11
  givenname: Paul
  surname: Timpson
  fullname: Timpson, Paul
  organization: St Vincent's Hospital Clinical School, University of New South Wales, Sydney, Australia, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia
– sequence: 12
  givenname: Jason E
  orcidid: 0000-0003-3987-5894
  surname: Cain
  fullname: Cain, Jason E
  organization: Hudson Institute of Medical Research, Clayton, Australia, Department of Molecular and Translational Medicine, School of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia
– sequence: 13
  givenname: D Neil
  orcidid: 0000-0001-8218-4920
  surname: Watkins
  fullname: Watkins, D Neil
  organization: Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, Canada, Department of Internal Medicine, Rady Faculty of Health Science, University of Manitoba, Winnipeg, Canada
– sequence: 14
  givenname: David R
  orcidid: 0000-0003-4965-8674
  surname: Croucher
  fullname: Croucher, David R
  organization: St Vincent's Hospital Clinical School, University of New South Wales, Sydney, Australia, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia
– sequence: 15
  givenname: Andrew
  orcidid: 0000-0003-4536-9226
  surname: Burgess
  fullname: Burgess, Andrew
  organization: ANZAC Research Institute, Concord Hospital, Concord, Australia
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33983115$$D View this record in MEDLINE/PubMed
BookMark eNptktuL1DAUxoOsuOu4T75LwRdFO-be9kUYFi8DA4IXEHwIaXrSzdAms00r7n9vOrOrO8smkITkd75wPr6n6MQHDwg9J3hZCMHfwcZZWEpBGX-EzigWOMcl_3ly53yKzmPc4jQKXpakeoJOGatKRog4Q79WWVLMW_AwOvM2M9B1mbk2HeQN7MA34MesB3OpvYt9Fmy26_To_NRnA0QXR-0NZM5n3eTbTCc8GD0Y50Ovn6HHVncRzm_2Bfrx8cP3i8_55sun9cVqkxtRyDGvMVBZFBSDIVziumy0YJoXnJsaOJaWWtYUgtWkYTW2Vc0AS8l5zZloLOdsgdYH3SbordoNrtfDtQraqf1FGFqlh9RdB4pSUlIpNNVUcoGhxqyhBVgGyRLMaNJ6f9DaTXUPjUntD7o7Ej1-8e5SteG3KomsCJ0FXt0IDOFqgjiq3sXZVe0hTFFRQSXDvEjrAr28h27DNPhkVaIqQaqKk-I_1erUgPM2pH_NLKpWUrKCJaxK1PIBKs0GemdSZqxL90cFr48KEjPCn7HVU4xq_e3rMfvirin_3LiNUQLIATBDiHEAq4wbU0zC7JHrFMFqTqvap1Xt05pq3tyruZV9iP4LyzvoNQ
CitedBy_id crossref_primary_10_1038_s41418_021_00875_z
crossref_primary_10_1080_00387010_2024_2384603
crossref_primary_10_1038_s41419_024_06690_x
crossref_primary_10_3389_fimmu_2022_1058493
crossref_primary_10_3390_biom13111587
crossref_primary_10_3390_ijms241713208
crossref_primary_10_3390_jcm12020599
crossref_primary_10_1080_15384101_2022_2031770
crossref_primary_10_1146_annurev_cancerbio_071924_084617
crossref_primary_10_3389_fphar_2023_1105484
crossref_primary_10_1038_s41416_022_01899_z
crossref_primary_10_1038_s41540_024_00397_7
crossref_primary_10_3390_ph17091118
crossref_primary_10_1242_jcs_260458
crossref_primary_10_1038_s41568_022_00500_2
crossref_primary_10_1016_j_cellsig_2024_111402
Cites_doi 10.1038/srep10129
10.1038/s41467-017-00339-4
10.1093/nar/gks670
10.3389/fcell.2020.00305
10.1038/nrc2167
10.1182/blood-2019-121229
10.4161/cc.28401
10.1101/gr.1239303
10.1038/mt.2008.6
10.1126/scitranslmed.aat3504
10.1073/pnas.2009506117
10.1021/js960037a
10.1146/annurev-cancerbio-030518-055914
10.3390/cancers12082285
10.1111/j.1365-2125.2004.02082.x
10.18632/oncotarget.8110
10.1007/s10637-020-00898-2
10.1038/s41556-017-0011-1
10.1038/nmeth.2019
10.1186/s13059-014-0550-8
10.1093/bioinformatics/btx100
10.7554/eLife.53367
10.1016/j.mex.2019.10.014
10.1186/gb-2010-11-10-r106
10.1016/j.critrevonc.2007.02.001
10.1016/j.cell.2007.12.033
10.1038/ncomms14728
10.1038/nmeth.1269
10.1093/nar/gky764
10.1016/j.molcel.2012.05.052
10.3389/fonc.2014.00140
10.1038/nature25183
10.1016/j.ccell.2020.01.007
10.1080/15384101.2018.1515555
10.1038/s41388-018-0295-z
10.1038/s41556-019-0293-6
10.1038/nprot.2012.026
10.1093/nar/29.1.308
10.1038/sj.onc.1203935
10.1101/sqb.2017.82.033647
10.1073/pnas.0506580102
10.1038/nprot.2013.026
10.1126/science.aap9346
10.1016/j.cell.2008.12.020
10.1093/emboj/cdg387
10.3791/1278
10.1038/s41598-017-17204-5
10.1038/nm.2338
10.1038/s41591-018-0009-7
10.1038/onc.2012.615
10.1371/journal.pone.0045726
10.1016/j.celrep.2017.09.022
10.1093/bioinformatics/bts635
10.2217/lmt-2016-0004
10.1038/nbt.3122
10.1038/nrclinonc.2017.198
10.1016/j.cub.2014.01.019
10.1016/j.cell.2019.05.041
10.1038/s41467-018-06308-9
10.1038/ng1180
10.7554/eLife.58020
ContentType Journal Article
Copyright 2021, Gonzalez Rajal et al.
COPYRIGHT 2021 eLife Science Publications, Ltd.
2021, Gonzalez Rajal et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2021, Gonzalez Rajal et al 2021 Gonzalez Rajal et al
Copyright_xml – notice: 2021, Gonzalez Rajal et al.
– notice: COPYRIGHT 2021 eLife Science Publications, Ltd.
– notice: 2021, Gonzalez Rajal et al. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2021, Gonzalez Rajal et al 2021 Gonzalez Rajal et al
DBID AAYXX
CITATION
NPM
ISR
3V.
7X7
7XB
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.7554/eLife.65234
DatabaseName CrossRef
PubMed
Gale In Context: Science
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
ProQuest Health & Medical Collection
Medical Database
Science Database
Biological Science Database
ProQuest Databases
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed
Publicly Available Content Database
CrossRef


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2050-084X
ExternalDocumentID oai_doaj_org_article_2218265a2a26450eb03d27ef3e339032
PMC8169122
A663739949
33983115
10_7554_eLife_65234
Genre Journal Article
GeographicLocations Fiji
GeographicLocations_xml – name: Fiji
GrantInformation_xml – fundername: Cancer Institute NSW
  grantid: 10/FRL/3-02
– fundername: Tour de Cure
  grantid: RSP-230-2020
– fundername: Cancer Institute NSW
  grantid: 15/REG/1-17
– fundername: National Breast Cancer Foundation
  grantid: IIRS-18-103
– fundername: Cancer Institute NSW
  grantid: 2013/FRL102
– fundername: ;
  grantid: 15/REG/1-17
– fundername: ;
  grantid: 10/FRL/3-02
– fundername: ;
  grantid: 2013/FRL102
– fundername: ;
  grantid: RSP-230-2020
– fundername: ;
  grantid: IIRS-18-103
GroupedDBID 53G
5VS
7X7
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAKDD
AAYXX
ABUWG
ACGFO
ACGOD
ACPRK
ADBBV
ADRAZ
AENEX
AFFHD
AFKRA
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
CCPQU
CITATION
DIK
DWQXO
EMOBN
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HMCUK
HYE
IAO
IEA
IHR
INH
INR
ISR
ITC
KQ8
LK8
M1P
M2P
M48
M7P
M~E
NQS
OK1
PGMZT
PHGZM
PHGZT
PIMPY
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
RHI
RNS
RPM
UKHRP
ALIPV
NPM
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c576t-b0e267720ec1460b8da53a4744cbe406f2f3d753b1d3b0f9b3e06644b435df443
IEDL.DBID M7P
ISICitedReferencesCount 20
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000658379300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2050-084X
IngestDate Tue Oct 14 19:08:31 EDT 2025
Tue Nov 04 01:45:16 EST 2025
Thu Sep 04 17:08:42 EDT 2025
Tue Oct 07 07:03:08 EDT 2025
Tue Nov 11 10:10:37 EST 2025
Tue Nov 04 17:46:51 EST 2025
Thu Nov 13 15:00:07 EST 2025
Mon Jul 21 05:55:47 EDT 2025
Sat Nov 29 06:24:12 EST 2025
Tue Nov 18 22:25:18 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords human
cancer biology
cell biology
Language English
License 2021, Gonzalez Rajal et al.
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c576t-b0e267720ec1460b8da53a4744cbe406f2f3d753b1d3b0f9b3e06644b435df443
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
ORCID 0000-0002-9420-9352
0000-0003-3332-5074
0000-0003-4536-9226
0000-0001-8218-4920
0000-0002-1861-1390
0000-0003-4965-8674
0000-0002-3051-2205
0000-0002-9230-0339
0000-0003-2839-4358
0000-0003-3987-5894
OpenAccessLink https://www.proquest.com/docview/2595199417?pq-origsite=%requestingapplication%
PMID 33983115
PQID 2595199417
PQPubID 2045579
ParticipantIDs doaj_primary_oai_doaj_org_article_2218265a2a26450eb03d27ef3e339032
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8169122
proquest_miscellaneous_2526304726
proquest_journals_2595199417
gale_infotracmisc_A663739949
gale_infotracacademiconefile_A663739949
gale_incontextgauss_ISR_A663739949
pubmed_primary_33983115
crossref_citationtrail_10_7554_eLife_65234
crossref_primary_10_7554_eLife_65234
PublicationCentury 2000
PublicationDate 2021-05-13
PublicationDateYYYYMMDD 2021-05-13
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-13
  day: 13
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Cambridge
PublicationTitle eLife
PublicationTitleAlternate Elife
PublicationYear 2021
Publisher eLife Science Publications, Ltd
eLife Sciences Publications Ltd
eLife Sciences Publications, Ltd
Publisher_xml – name: eLife Science Publications, Ltd
– name: eLife Sciences Publications Ltd
– name: eLife Sciences Publications, Ltd
References Ritsma (bib40) 2013; 8
Kelland (bib29) 2007; 7
Subramanian (bib56) 2005; 102
Mamdani (bib32) 2016; 5
Mootha (bib35) 2003; 34
Chan (bib10) 2018; 20
Charrasse (bib12) 2017; 8
Hastings (bib21) 2020; 9
Steigemann (bib54) 2009; 136
Gonzalez (bib19) 2021
Salvador-Barbero (bib44) 2020; 37
Weber (bib62) 2011; 17
Hayashi (bib22) 2013; 32
McCloy (bib34) 2014; 13
Andersson (bib2) 1996; 85
Schmidt (bib48) 2018
Gonzalez-Rajal (bib20) 2020; 8
Replogle (bib39) 2020; 117
Smogorzewska (bib52) 2019; 134
Anders (bib1) 2010; 11
Bankhead (bib4) 2017; 7
Enoiu (bib15) 2012; 40
Sakaue-Sawano (bib42) 2008; 132
Marini (bib33) 2018; 10
Burgess (bib8) 2014; 4
Nobis (bib37) 2017; 21
Herbst (bib23) 2018; 553
Pertea (bib38) 2015; 33
Chan (bib11) 2018; 17
Feringa (bib16) 2018; 9
Urien (bib59) 2004; 57
Murai (bib36) 2018; 3
Sherry (bib50) 2001; 29
Slyskova (bib51) 2018; 46
Baus (bib6) 2003; 22
Stewart (bib55) 2007; 63
Caldon (bib9) 2019; 6
Luong (bib31) 2016; 7
Sarlós (bib46) 2017
Garrison (bib17) 2021
Schindelin (bib47) 2012; 9
Weber (bib61) 2008; 16
Kawabe (bib27) 2000; 19
Danecek (bib13) 2017; 33
Weber (bib63) 2012; 7
Bakhoum (bib3) 2014; 24
Burgess (bib7) 2012; 7
Barr (bib5) 2017; 8
Dobin (bib14) 2013; 29
Rogers (bib41) 2018; 37
Sansregret (bib45) 2018; 15
Saldivar (bib43) 2018; 361
Spies (bib53) 2019; 21
Yang (bib64) 2015; 5
Hsu (bib24) 2019; 178
Johnson (bib25) 2020; 12
Kedrin (bib28) 2008; 5
Tutt (bib58) 2018; 24
Watts (bib60) 2020; 9
Gligorijevic (bib18) 2009; 28
Shannon (bib49) 2003; 13
Swiecicki (bib57) 2020; 38
Love (bib30) 2014; 15
Karanam (bib26) 2012; 47
References_xml – volume: 5
  year: 2015
  ident: bib64
  article-title: Single cell resolution in vivo imaging of DNA damage following PARP inhibition
  publication-title: Scientific Reports
  doi: 10.1038/srep10129
– volume: 8
  year: 2017
  ident: bib12
  article-title: Ensa controls S-phase length by modulating treslin levels
  publication-title: Nature Communications
  doi: 10.1038/s41467-017-00339-4
– volume: 40
  start-page: 8953
  year: 2012
  ident: bib15
  article-title: Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis
  publication-title: Nucleic Acids Research
  doi: 10.1093/nar/gks670
– volume: 8
  year: 2020
  ident: bib20
  article-title: Breathing new life into the mechanisms of platinum resistance in lung adenocarcinoma
  publication-title: Frontiers in Cell and Developmental Biology
  doi: 10.3389/fcell.2020.00305
– volume: 7
  start-page: 573
  year: 2007
  ident: bib29
  article-title: The resurgence of platinum-based Cancer chemotherapy
  publication-title: Nature Reviews Cancer
  doi: 10.1038/nrc2167
– volume: 134
  year: 2019
  ident: bib52
  article-title: Fanconi Anemia: a paradigm for understanding DNA repair during replication
  publication-title: Blood
  doi: 10.1182/blood-2019-121229
– volume: 13
  start-page: 1400
  year: 2014
  ident: bib34
  article-title: Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events
  publication-title: Cell Cycle Georget Tex
  doi: 10.4161/cc.28401
– volume: 13
  start-page: 2498
  year: 2003
  ident: bib49
  article-title: Cytoscape: a software environment for integrated models of biomolecular interaction networks
  publication-title: Genome Research
  doi: 10.1101/gr.1239303
– volume: 16
  start-page: 698
  year: 2008
  ident: bib61
  article-title: A multicolor panel of novel lentiviral "gene ontology" (LeGO) vectors for functional gene analysis
  publication-title: Molecular Therapy
  doi: 10.1038/mt.2008.6
– volume: 10
  year: 2018
  ident: bib33
  article-title: Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy
  publication-title: Science Translational Medicine
  doi: 10.1126/scitranslmed.aat3504
– volume: 117
  start-page: 30566
  year: 2020
  ident: bib39
  article-title: Aneuploidy increases resistance to chemotherapeutics by antagonizing cell division
  publication-title: PNAS
  doi: 10.1073/pnas.2009506117
– volume: 85
  start-page: 824
  year: 1996
  ident: bib2
  article-title: Pharmacokinetics of cisplatin and its monohydrated complex in humans
  publication-title: Journal of Pharmaceutical Sciences
  doi: 10.1021/js960037a
– volume: 3
  start-page: 1
  year: 2018
  ident: bib36
  article-title: PARP trapping beyond homologous recombination and platinum sensitivity in cancers
  publication-title: Annu Rev Cancer Biology
  doi: 10.1146/annurev-cancerbio-030518-055914
– volume: 12
  year: 2020
  ident: bib25
  article-title: YB-1 knockdown inhibits the proliferation of mesothelioma cells through multiple mechanisms
  publication-title: Cancers
  doi: 10.3390/cancers12082285
– volume: 57
  start-page: 756
  year: 2004
  ident: bib59
  article-title: Population pharmacokinetics of total and unbound plasma cisplatin in adult patients
  publication-title: British Journal of Clinical Pharmacology
  doi: 10.1111/j.1365-2125.2004.02082.x
– volume: 7
  start-page: 23383
  year: 2016
  ident: bib31
  article-title: Cell fate determination in cisplatin resistance and chemosensitization
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.8110
– volume: 38
  start-page: 1550
  year: 2020
  ident: bib57
  article-title: A multi-center phase II trial evaluating the efficacy of palbociclib in combination with carboplatin for the treatment of unresectable recurrent or metastatic head and neck squamous cell carcinoma
  publication-title: Investigational New Drugs
  doi: 10.1007/s10637-020-00898-2
– volume: 20
  start-page: 92
  year: 2018
  ident: bib10
  article-title: Unresolved recombination intermediates lead to ultra-fine anaphase bridges, chromosome breaks and aberrations
  publication-title: Nature Cell Biology
  doi: 10.1038/s41556-017-0011-1
– volume: 9
  start-page: 676
  year: 2012
  ident: bib47
  article-title: Fiji: an open-source platform for biological-image analysis
  publication-title: Nature Methods
  doi: 10.1038/nmeth.2019
– volume: 15
  year: 2014
  ident: bib30
  article-title: Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
  publication-title: Genome Biology
  doi: 10.1186/s13059-014-0550-8
– volume: 33
  start-page: 2037
  year: 2017
  ident: bib13
  article-title: BCFtools/csq: haplotype-aware variant consequences
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btx100
– volume: 9
  year: 2020
  ident: bib21
  article-title: Analysis of pulsed cisplatin signalling dynamics identifies effectors of resistance in lung adenocarcinoma
  publication-title: eLife
  doi: 10.7554/eLife.53367
– volume: 6
  start-page: 2468
  year: 2019
  ident: bib9
  article-title: Label free, quantitative single-cell fate tracking of time-lapse movies
  publication-title: MethodsX
  doi: 10.1016/j.mex.2019.10.014
– volume: 11
  year: 2010
  ident: bib1
  article-title: Differential expression analysis for sequence count data
  publication-title: Genome Biology
  doi: 10.1186/gb-2010-11-10-r106
– volume: 63
  start-page: 12
  year: 2007
  ident: bib55
  article-title: Mechanisms of resistance to cisplatin and carboplatin
  publication-title: Critical Reviews in Oncology/Hematology
  doi: 10.1016/j.critrevonc.2007.02.001
– volume: 132
  start-page: 487
  year: 2008
  ident: bib42
  article-title: Visualizing spatiotemporal dynamics of multicellular cell-cycle progression
  publication-title: Cell
  doi: 10.1016/j.cell.2007.12.033
– volume: 8
  year: 2017
  ident: bib5
  article-title: DNA damage during S-phase mediates the proliferation-quiescence decision in the subsequent G1 via p21 expression
  publication-title: Nature Communications
  doi: 10.1038/ncomms14728
– volume: 5
  start-page: 1019
  year: 2008
  ident: bib28
  article-title: Intravital imaging of metastatic behavior through a mammary imaging window
  publication-title: Nature Methods
  doi: 10.1038/nmeth.1269
– volume: 46
  start-page: 9537
  year: 2018
  ident: bib51
  article-title: Base and nucleotide excision repair facilitate resolution of platinum drugs-induced transcription blockage
  publication-title: Nucleic Acids Research
  doi: 10.1093/nar/gky764
– volume: 47
  start-page: 320
  year: 2012
  ident: bib26
  article-title: Quantitative live cell imaging reveals a gradual shift between DNA repair mechanisms and a maximal use of HR in mid S phase
  publication-title: Molecular Cell
  doi: 10.1016/j.molcel.2012.05.052
– volume: 4
  year: 2014
  ident: bib8
  article-title: Stressing mitosis to death
  publication-title: Frontiers in Oncology
  doi: 10.3389/fonc.2014.00140
– volume: 553
  start-page: 446
  year: 2018
  ident: bib23
  article-title: The biology and management of non-small cell lung Cancer
  publication-title: Nature
  doi: 10.1038/nature25183
– volume: 37
  start-page: 340
  year: 2020
  ident: bib44
  article-title: CDK4/6 inhibitors impair recovery from cytotoxic chemotherapy in pancreatic adenocarcinoma
  publication-title: Cancer Cell
  doi: 10.1016/j.ccell.2020.01.007
– volume: 17
  start-page: 2101
  year: 2018
  ident: bib11
  article-title: A new class of ultrafine anaphase bridges generated by homologous recombination
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2018.1515555
– volume: 37
  start-page: 4518
  year: 2018
  ident: bib41
  article-title: MASTL overexpression promotes chromosome instability and metastasis in breast Cancer
  publication-title: Oncogene
  doi: 10.1038/s41388-018-0295-z
– volume: 21
  start-page: 487
  year: 2019
  ident: bib53
  article-title: 53bp1 nuclear bodies enforce replication timing at under-replicated DNA to limit heritable DNA damage
  publication-title: Nature Cell Biology
  doi: 10.1038/s41556-019-0293-6
– volume-title: Software Heritage
  year: 2021
  ident: bib19
  article-title: freebayes, a haplotype-based variant detector
– volume: 7
  start-page: 839
  year: 2012
  ident: bib63
  article-title: RGB marking with lentiviral vectors for multicolor clonal cell tracking
  publication-title: Nature Protocols
  doi: 10.1038/nprot.2012.026
– volume: 29
  start-page: 308
  year: 2001
  ident: bib50
  article-title: dbSNP: the NCBI database of genetic variation
  publication-title: Nucleic Acids Research
  doi: 10.1093/nar/29.1.308
– volume: 19
  start-page: 5359
  year: 2000
  ident: bib27
  article-title: Adenovirus-mediated p16INK4a gene expression radiosensitizes non-small cell lung Cancer cells in a p53-dependent manner
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1203935
– start-page: 187
  year: 2017
  ident: bib46
  article-title: Knotty problems during mitosis: mechanistic insight into the processing of ultrafine DNA bridges in anaphase
  doi: 10.1101/sqb.2017.82.033647
– volume: 102
  start-page: 15545
  year: 2005
  ident: bib56
  article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles
  publication-title: PNAS
  doi: 10.1073/pnas.0506580102
– volume: 8
  start-page: 583
  year: 2013
  ident: bib40
  article-title: Surgical implantation of an abdominal imaging window for intravital microscopy
  publication-title: Nature Protocols
  doi: 10.1038/nprot.2013.026
– volume: 361
  start-page: 806
  year: 2018
  ident: bib43
  article-title: An intrinsic S/G2checkpoint enforced by ATR
  publication-title: Science
  doi: 10.1126/science.aap9346
– volume: 136
  start-page: 473
  year: 2009
  ident: bib54
  article-title: Aurora B-mediated abscission checkpoint protects against tetraploidization
  publication-title: Cell
  doi: 10.1016/j.cell.2008.12.020
– volume: 22
  start-page: 3992
  year: 2003
  ident: bib6
  article-title: Permanent cell cycle exit in G2 phase after DNA damage in normal human fibroblasts
  publication-title: The EMBO Journal
  doi: 10.1093/emboj/cdg387
– volume: 28
  year: 2009
  ident: bib18
  article-title: Dendra2 photoswitching through the mammary imaging window
  publication-title: Journal of Visualized Experiments
  doi: 10.3791/1278
– volume: 7
  year: 2017
  ident: bib4
  article-title: QuPath: open source software for digital pathology image analysis
  publication-title: Scientific Reports
  doi: 10.1038/s41598-017-17204-5
– volume: 17
  start-page: 504
  year: 2011
  ident: bib62
  article-title: RGB marking facilitates multicolor clonal cell tracking
  publication-title: Nature Medicine
  doi: 10.1038/nm.2338
– volume: 24
  start-page: 628
  year: 2018
  ident: bib58
  article-title: Carboplatin in BRCA1/2-mutated and triple-negative breast Cancer BRCAness subgroups: the TNT trial
  publication-title: Nature Medicine
  doi: 10.1038/s41591-018-0009-7
– volume: 32
  start-page: 4593
  year: 2013
  ident: bib22
  article-title: DNA damage associated with mitosis and cytokinesis failure
  publication-title: Oncogene
  doi: 10.1038/onc.2012.615
– volume-title: arXiv
  year: 2018
  ident: bib48
  article-title: Cell detection with Star-convex polygons
– volume: 7
  year: 2012
  ident: bib7
  article-title: Quantitative live imaging of endogenous DNA replication in mammalian cells
  publication-title: PLOS ONE
  doi: 10.1371/journal.pone.0045726
– volume: 21
  start-page: 274
  year: 2017
  ident: bib37
  article-title: A RhoA-FRET biosensor mouse for intravital imaging in normal tissue homeostasis and disease contexts
  publication-title: Cell Reports
  doi: 10.1016/j.celrep.2017.09.022
– volume: 29
  start-page: 15
  year: 2013
  ident: bib14
  article-title: STAR: ultrafast universal RNA-seq aligner
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/bts635
– volume-title: GitHub 
  year: 2021
  ident: bib17
  article-title: freebayes
– volume: 5
  start-page: 5
  year: 2016
  ident: bib32
  article-title: DNA repair in lung Cancer: potential not yet reached
  publication-title: Lung Cancer Management
  doi: 10.2217/lmt-2016-0004
– volume: 33
  start-page: 290
  year: 2015
  ident: bib38
  article-title: StringTie enables improved reconstruction of a transcriptome from RNA-seq reads
  publication-title: Nature Biotechnology
  doi: 10.1038/nbt.3122
– volume: 15
  start-page: 139
  year: 2018
  ident: bib45
  article-title: Determinants and clinical implications of chromosomal instability in Cancer
  publication-title: Nature Reviews Clinical Oncology
  doi: 10.1038/nrclinonc.2017.198
– volume: 24
  start-page: R148
  year: 2014
  ident: bib3
  article-title: The mitotic origin of chromosomal instability
  publication-title: Current Biology
  doi: 10.1016/j.cub.2014.01.019
– volume: 178
  start-page: 361
  year: 2019
  ident: bib24
  article-title: Patterns of early p21 dynamics determine Proliferation-Senescence cell fate after chemotherapy
  publication-title: Cell
  doi: 10.1016/j.cell.2019.05.041
– volume: 9
  year: 2018
  ident: bib16
  article-title: Persistent repair intermediates induce senescence
  publication-title: Nature Communications
  doi: 10.1038/s41467-018-06308-9
– volume: 34
  start-page: 267
  year: 2003
  ident: bib35
  article-title: PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
  publication-title: Nature Genetics
  doi: 10.1038/ng1180
– volume: 9
  year: 2020
  ident: bib60
  article-title: The RIF1-long splice variant promotes G1 phase 53bp1 nuclear bodies to protect against replication stress
  publication-title: eLife
  doi: 10.7554/eLife.58020
SSID ssj0000748819
Score 2.3868237
Snippet We previously used a pulse-based in vitro assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma...
We previously used a pulse-based assay to unveil targetable signalling pathways associated with innate cisplatin resistance in lung adenocarcinoma (Hastings et...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms 53BP1
Adenocarcinoma
Biosensors
BRCA1
Cancer Biology
Cancer therapies
Carboplatin
Cell Biology
Cell cycle
Cisplatin
Cyclin-dependent kinases
Deoxyribonucleic acid
DNA
DNA damage
DNA repair
Flow cytometry
G2 phase
Kinases
Lung cancer
mitosis
Ovaries
PARP1
Poly(ADP-ribose) polymerase
Research Advance
S phase
Senescence
Signal transduction
Testicular cancer
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3faxQxEB6kKPRF_FXdWiVKQSiu3Uuym93HUywKUqS1UPAhJNmkXejtlds7of-9M9m94xYFX3y9zC3JZDIz3-7kG4BDFUqrbB7SUNaGAIpIK1-K1BYud3WwIkgbm02o09Py8rL6vtXqi2rCenrgXnHHnCjGi9xwg6E7z7zNRM2VD8ILhOsiel_MerbAVPTBCg1zUvUX8hSGzGP_rQn-Q4G4S45CUGTq_9MfbwWkcbHkVvQ5eQQPh7SRTfvpPoZ7vn0CD_pGkndP4eeUIYxP0RjoTuJ7Rq_jmbtD0XTd5XbJZp5u-TbdjM0Du6UauHY1Ywi3KYXEvWdNy27w7DOD4hjiFq5p5zPzDC5OPv_49CUd2iakDsHDMrWZ5wUmzZl36AYzi5uQCyOVlM56jN-BB1EjSrGTWtgsVFZ4zDuktJg51UFKsQc7OGf_AlghyR_Qx7uikqXNTSZDLhw-yeFTgkngaK1J7QZOcWptcaMRW5DadVS7jmpP4HAjfNtTafxd7CNtyUaE-K_jD2gVerAK_S-rSOAtbagmhouWSmiuzKrr9NfzMz3FHEthWiarBN4NQmGOs3ZmuJGAaydSrJHkwUgSj6AbD6_tRg8uoNOIK3MiXp6oBN5shumfVNbW-vmKZHhB3z15kcDz3sw268aFlESFlIAaGeBIMeORtrmOBOElMSBxvv8_NPkSdjmV8RBhrTiAneVi5V_Bffdr2XSL1_HU_QafizCa
  priority: 102
  providerName: Directory of Open Access Journals
Title A non-genetic, cell cycle-dependent mechanism of platinum resistance in lung adenocarcinoma
URI https://www.ncbi.nlm.nih.gov/pubmed/33983115
https://www.proquest.com/docview/2595199417
https://www.proquest.com/docview/2526304726
https://pubmed.ncbi.nlm.nih.gov/PMC8169122
https://doaj.org/article/2218265a2a26450eb03d27ef3e339032
Volume 10
WOSCitedRecordID wos000658379300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2050-084X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000748819
  issn: 2050-084X
  databaseCode: DOA
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2050-084X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000748819
  issn: 2050-084X
  databaseCode: M~E
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2050-084X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000748819
  issn: 2050-084X
  databaseCode: M7P
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2050-084X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000748819
  issn: 2050-084X
  databaseCode: 7X7
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2050-084X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000748819
  issn: 2050-084X
  databaseCode: BENPR
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2050-084X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000748819
  issn: 2050-084X
  databaseCode: PIMPY
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 2050-084X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000748819
  issn: 2050-084X
  databaseCode: M2P
  dateStart: 20120101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYBhIvfH8ERmXQJCREtsx24uQJdWgTk1gVDZCKeLBixx6R1qQ0LdL-e-7cNCwC8cJLHuprZOfO9-Xz7wjZky7VUscudGlZYIDCw8ymPNSJiU3pNHdC-2YTcjJJp9Ms7xJubVdWudGJXlGXjcEc-QG46THi2B7Kd_MfIXaNwtPVroXGFtlBlATuS_fyPscC5jEFi7e-lifBcB7Yj5Wz-wlEX2JgiDxe_59a-ZpZGpZMXrNBJ3f_d_b3yJ3O-6TjtbjcJzds_YDcWvejvHpIvo1p3dQhyBRebXxLMatPzRWQhptmuUs6s3hZuGpntHF0jqV09WpGIWpHTxREiFY1vQQVQgsgB0u5MFXdzIpH5MvJ8ef3H8Ku-0JoIAZZhjqyLAHfO7IGtGmkgZcxL4QUwmgLboBjjpcQ7OjDkuvIZZpbcF-E0OCAlU4I_phsw5ztU0ITgWoFzwCTTKQ6LiLhYm7gTQbe4oqAvNmwQpkOmhw7ZFwqCFGQb8rzTXm-BWSvJ56vETn-TnaEPO1JEEbb_9AsLlS3KxVD_PokLlgBfmEcWR3xkknruOU8izgLyCuUCIVAGTVW4lwUq7ZVp5_O1RhcNQnencgC8rojcg3M2hTdxQZYO2JrDSh3B5Swk81weCM8qtMkrfotOQF52Q_jP7E6rrbNCmlYgsenLAnIk7Wc9uuGhaSIqBQQOZDgwYcZjtTVd48zniKQEmPP_j2t5-Q2wzofRLTlu2R7uVjZF-Sm-bms2sWIbMmp9M90RHaOjif5-cjnPeB5xvKR37Awkp-e5V9_AbO1R2M
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VFAQX3g9DgQUVISFM3d3164BQeFSNmkYVFKmIg_Gud4ulxg5xAsqf4jcy49ihFohbD1yzk9WuPY9vvTPfAGyGNlKh8q1royylA4pwYxMJVwXa15lVwkpVN5sIR6Po6Cg-WIOfbS0MpVW2PrF21Fmp6Rv5FsJ0n3hst8NXk28udY2i29W2hcZSLfbM4gce2aqXg7f4fp9wvvPu8M2u23QVcDVi65mrPMMDxJSe0eglPIVr9EUqQym1MhjeLLciQxCvtjOhPBsrYTAsS6kQWGRWSoHznoN1icoe9WD9YLB_8Gn1VQcDcoQxdlkIGGKo3jLD3JoXAZ73ZCf01R0C_owDpwJhN0nzVNTbufK_Pa-rcLnB16y_NIhrsGaK63Bh2XFzcQM-91lRFi5aDRVvPmd0b8H0AkXdth3wjI0NlUPn1ZiVlk0oWbCYj9nUVIS10UhYXrATdJIsRXHEAlOdF-U4vQkfz2Rnt6CHazZ3gAWSHCfdcgaxjJSfetL6QuNMGmexqQPP2lef6IZ8nXqAnCR4CCM9SWo9SWo9cWBzJTxZco78Xew16dBKhIjC6x_K6XHS-J2EE0N_4Kc8ReTre0Z5IuOhscIIEXuCO_CYNDAhKpCCco2O03lVJYMP75M-gtEQ8auMHXjaCNkSV63TpnQD907sYR3JjY4k-irdHW6VNWl8ZZX81lQHHq2G6Z-U_1eYck4yPKALYh44cHtpF6t940Yi4oxyIOxYTOfBdEeK_GvNpB4RVRTnd_-9rIdwcfdwf5gMB6O9e3CJU1YT8feKDejNpnNzH87r77O8mj5o3AGDL2dtUb8ADHOdvg
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9QwEB6VcogX7iNQwKAiJETY1HauB4QWyopVq1UFRarEQ4gdu0TqJstmF7R_jV_HTI6lEYi3PvC6nrXsZI7P8cw3ANuhjVSofOvaKEvpgCLc2ETCVYH2dWaVsFLVzSbCySQ6OooPNuBnVwtDaZWdT6wddVZq-kY-QJjuE4_tTjiwbVrEwe7o9eybSx2k6Ka1a6fRqMieWf3A41v1aryL7_op56N3h2_fu22HAVcjzl64yjM8QHzpGY0ew1O4Xl-kMpRSK4OhznIrMgT0aicTyrOxEgZDtJQKQUZmpRQ47zk4HxJpeZ02eLD-voOhOcJo25QEhhi0B2Y_t-ZlgCc_2QuCda-APyPCqZDYT9c8Ff9GV__nJ3cNrrSomw0bM7kOG6a4ARebPpyrm_B5yIqycNGWqKTzBaPbDKZXKOp2TYIXbGqoSDqvpqy0bEYphMVyyuamIgSOpsPygp2g62QpiiNCmOu8KKfpLfh0Jju7DZu4ZnMXWCDJndLdZxDLSPmpJ60vNM6kcRabOvC8U4NEt5Ts1BnkJMGjGelMUutMUuuMA9tr4VnDRPJ3sTekT2sRog-vfyjnx0nrjRJOvP2Bn_IU8bDvGeWJjIfGCiNE7AnuwBPSxoQIQgpSmON0WVXJ-OOHZIgQNURUK2MHnrVCtsRV67Qt6MC9E6dYT3KrJ4keTPeHO8VNWg9aJb-11oHH62H6J2UFFqZckgwP6NqYBw7caWxkvW_cSERMUg6EPevpPZj-SJF_rfnVIyKQ4vzev5f1CC6hGSX748nefbjMKdWJSH3FFmwu5kvzAC7o74u8mj-s_QKDL2dtTr8AYBWk_Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+non-genetic%2C+cell+cycle-dependent+mechanism+of+platinum+resistance+in+lung+adenocarcinoma&rft.jtitle=eLife&rft.au=Gonzalez+Rajal%2C+Alvaro&rft.au=Marzec%2C+Kamila+A&rft.au=McCloy%2C+Rachael+A&rft.au=Nobis%2C+Max&rft.date=2021-05-13&rft.pub=eLife+Science+Publications%2C+Ltd&rft.issn=2050-084X&rft.eissn=2050-084X&rft.volume=10&rft_id=info:doi/10.7554%2FeLife.65234&rft.externalDBID=ISR&rft.externalDocID=A663739949
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2050-084X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2050-084X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2050-084X&client=summon